(Q44541877)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12906987%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Sympatholysis and cardiac sympathetic nerve function in the treatment of congestive heart failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12906987%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

congestive heart failure

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12906987%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

Chang-seng Liang

series ordinal

1

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12906987%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American College of Cardiology

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12906987%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12906987%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12906987%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

549-551

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12906987%20AND%20SRC:MED&resulttype=core&format=json

Augmentation of the plasma nor-epinephrine response to exercise in patients with congestive heart failure

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900643-0

7 January 2021

beta-adrenergic receptor blockade in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900643-0

7 January 2021

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900643-0

7 January 2021

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900643-0

7 January 2021

Pharmacology of moxonidine, an I1-imidazoline receptor agonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900643-0

7 January 2021

Acute hemodynamic and neurohumoral effects of moxonidine in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900643-0

7 January 2021

Effects of sustained-release moxonidine, an imidazoline agonist, on plasma norepinephrine in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900643-0

7 January 2021

Cardiac and systemic sympathetic activity in response to clonidine in human heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900643-0

7 January 2021

Heart Failure 99 -- the MOXCON story

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900643-0

7 January 2021

Long-term treatment with low-dose, but not high-dose, guanethidine improves ventricular function and survival of rats with heart failure after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900643-0

7 January 2021

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900643-0

7 January 2021

Ultrastructural and immunohistologic characterization of guanethidine-induced destruction of peripheral sympathetic neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900643-0

7 January 2021

Effect of immunosuppressive agents on the guanethidine-induced sympathectomy in athymic and euthymic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900643-0

7 January 2021

Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900643-0

7 January 2021

Beneficial effects of metoprolol on myocardial sympathetic function: Evidence from a randomized, placebo-controlled study in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900643-0

7 January 2021

Increased myocardial [123I]-metaiodobenzylguanidine uptake after enalapril treatment in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900643-0

7 January 2021

A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900643-0

7 January 2021

Effects of bucindolol on neurohormonal activation in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900643-0

7 January 2021

Alterations in cardiac beta-adrenoceptor responsiveness and adenylate cyclase system by congestive heart failure in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900643-0

7 January 2021

Decreased adrenergic neuronal uptake activity in experimental right heart failure. A chamber-specific contributor to beta-adrenoceptor downregulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900643-0

7 January 2021

Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900643-0

7 January 2021

Beta-adrenoceptor downregulation in pacing-induced heart failure is associated with increased interstitial NE content.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900643-0

7 January 2021

Alterations in cardiac adrenergic terminal function and beta-adrenoceptor density in pacing-induced heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900643-0

7 January 2021

Myocardial beta-adrenoceptor down-regulation by norepinephrine is linked to reduced norepinephrine uptake activity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900643-0

7 January 2021

Ventricular hypertrophy plus neurohumoral activation is necessary to alter the cardiac beta-adrenoceptor system in experimental heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900643-0

7 January 2021

Chamber-specific alterations of noradrenaline uptake (uptake(1)) in right ventricles of monocrotaline-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900643-0

7 January 2021

Differential pre- and postsynaptic effects of desipramine on cardiac sympathetic nerve terminals in RHF.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900643-0

7 January 2021

Selegiline improves cardiac sympathetic terminal function and beta-adrenergic responsiveness in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900643-0

7 January 2021

Recovery of cardiac norepinephrine concentration and tyrosine hydroxylase activity by the central alpha2-adrenoceptor agonist guanabenz in rats with aortic constriction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900643-0

7 January 2021

Feedback inhibition of catecholamine release by two different alpha2-adrenoceptor subtypes prevents progression of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900643-0

7 January 2021